START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

Similar documents
Geriatric Pharmacology

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Polypharmacy & De-prescribing In Older Adults

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

Pharmacology in the Elderly

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Safe Medication Use. Holly Divine, PharmD, CGP, CDE. University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science

Screening tools for elderly patients in primary care

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

ARIC Manuscript Proposal #2493. PC Reviewed: 2/10/15 Status: A Priority: 2 SC Reviewed: Status: Priority:

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

Prescribing and Pharmacokinetic Considerations in the Elderly

Rebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L.

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

Physical and Sensory Changes in the Older Adult: Considerations for Medication Management

Katee Kindler, PharmD, BCACP

Polypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging

A Step Forward: Promoting Independence through Falls Prevention

Family Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD

How to Teach About Drugs and Aging

Prescribing Drugs to the Elderly

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD

Variation in drug responses & Drug-Drug Interactions

TOP 5 DRUGS.. TO AVOID IN THE ELDERLY

Pharmaceutical Care for Geriatrics

DEPRESCRIBING IN THE ELDERLY

Deprescribing with Confidence Dr Sanjay Suman MD FRCP

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND THE OLDER ADULT

Polypharmacy in the Elderly

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS

Rational Pharmacotherapy for LUTS in Older People. Dr William Gibson MBChB MRCP

Learning Objectives 2/4/2016. Patrick Leung, Pharm.D., BCPS, PhC. Patrick Leung, Pharm.D., BCPS, PhC Davena Norris, Pharm.D., BCPS, PhC 2/20/2016

Medication Management. Medications: The Right Balance. Who are we talking about? Geriatric Syndromes 9/19/2016. Older adults are a heterogenous group!

Medication safety in vulnerable patient groups - Elderly patients -

Medication Use in Older Adults

Interdisciplinary detection of potential drug related problems in older people

STOPP and START criteria October 2011

Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

Biology of Aging. Faculty Disclosure. Learning Objectives. I have no relevant financial disclosures relative to the content of this presentation.

Rationalizing Medications. Tan Jianming Senior Pharmacist KTPH

Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018

Use caution in the elderly: review of safe and effective medication use in older patients

STOPP START Toolkit Supporting Medication Review in the Older Person

Intelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork

Preventing Falls in Older Adults A Matter of Safety

USING MTM TO IMPROVE STAR RATINGS : CASE STUDIES

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

Introducing Pharmacokinetics and Pharmacodynamics. Janice Davies Pharmacist Room 23 Maudland Building

Open Access. A Prospective Study on Medication Prescribing Pattern for Geriatric Patients in a Tertiary Care Teaching Hospital

Aging Changes That Impact Medication Management

Presented by: Ontario s Geriatric Steering Committee

CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS

Polypharmacy and Polymorbid Patients: Practical Tips and Tricks

Deprescribing Unnecessary Medications: A Four-Part Process

Conflict of interest declaration and sources of funding

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017

Iatrogenic Delirium. Heather Carey, PharmD, BCPP Clinical Psychiatric Pharmacist University Hospitals Richmond Medical Center

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Strategies to Decrease Medication Errors in Elderly. Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS

Pitfalls in Pharmacotherapy of Geriatrics

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Navigating the Road to Efficient Medication Use

Pharmacotherapy In Geriatrics: Cause For Concern

Chitra Fernando, MD March 18, 2008

< = > less is more. De-diagnosing De-prescribing Non-testing

ROAD TO UNDERSTANDING POLYPHARMACY. Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP

Aspirin and Sta,ns and Benzos! Oh My! Polypharmacy in the Older Adult

Prescribing in the Elderly. Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry

Medication Management When Caring for Seniors at Home

Taking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian

Disclosure and Acknowledgements

Optimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014

Association between Potentially Inappropriate Prescription (PIP) and Health Outcome Among Geriatric Home Residents

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

NOCDURNA (desmopressin acetate) sublingual tablets Initial U.S. Approval: 1978

OBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics

Let it go! Rationalising medicines for patients with life limiting illness

Meds and Falls: Keep in Step with your Meds

Disclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults

The Use, Misuse and Abuse of Alcohol, and Psychoactive Drugs among Older Persons

DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 37 TOP: NURSING PROCESS: General MSC: NCLEX: Health Promotion and Maintenance

Summary of Lothian Joint Formulary Amendments

2/11/2016. Managing Polypharmacy: Evidence-based Dissection of Pharmaceuticals. Disclosure. Objectives

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation

Symptom Management Challenges at End-of-Life

INSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4

Transcription:

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment options among geriatric patients Identify and review common references for optimizing medication use in the elderly Conduct a patient chart review and identify factors which may influence and/or contribute to potentially inappropriate treatment options among geriatrics Review pertinent counseling points for common Beers List, STOPP, and START criteria medications as it applies to geriatric patients BACKGROUND 1

What is Geriatrics? Geriatrics refers to the medical care of the elderly Who is elderly? Difficult to define and resource dependent Typically defined as those aged 60 to 65 years and older Why is Geriatrics important? Physiologic changes among older adults Polypharmacy Potentially inappropriate medications (PIMs) Misuse vs. Under use Medications to avoid Adverse Drug Reactions (ADRs) 25% of ER visits related to ADRs are for elderly patients Drug-Drug Interactions (DDIs) Physiologic Changes in the Elderly PROCESS PHYSIOLOGIC CHANGE CLINICAL SIGNIFICANCE Absorption Decreased gastric acid production (increased gastric ph) Decreased gastric emptying Decreased GI motility Decreased GI blood flow Decreased absorptive surface area Possible reduction of tablet dissolution Possible reduction in solubility Increase exposure time in stomach Distribution Decreased total body mass (lean) Increased body fat Decreased total body water Decreased plasma albumin Altered protein binding Influence dosing weight Alter the onset and duration of water-soluable and highly-tissue bound drugs May delay onset of action among lipophilic drugs 2

Physiologic Changes in the Elderly PROCESS PHYSIOLOGIC CHANGE CLINICAL SIGNIFICANCE Metabolism Excretion Tissue Sensitivity Reduced liver mass Reduced blood flow to liver Reduced Phase I metabolism Reduced enzyme activity Reduced renal blood flow Reduced glomerular filtration Reduced function of tubular secretion Alterations in receptor numbers and affinity Alterations in second messanger function s Alterations in cellular and nuclear responses Decreased first passmetabolism Decreased renal elimination Variable sensitivity to drugs Could result in ADE, therapy failure, or insignificant responses Physiologic Changes in the Elderly PHYSIOLOGIC CHANGE Cognitive function may decrease over time Bone loss CLINICAL SIGNIFICANCE May impair understanding and adherence to medication regimen Increase fall risk Increased fracture Gait may slow and balance may worsen May increase fall and fracture risk Polypharmacy What is polypharmacy? Various defined Refers to the use of multiple medications Why is it a concern? Multiple provides Prescribing cascades Increase risk for DDIs and ADRs Inappropriate dosing and prescribing 3

QUESTION #1 Which of the following factors can influence medication dosing among the elderly? a) delayed gastric emptying b) declining kidney and liver function c) co-morbidities d) reduced and/or increased sensitivity to certain medications e) all of the above Introduction to Geriatric References Beers Criteria START Criteria STOPP Criteria Canadian Criteria Consider these tools, not rules 2012 AGS BEERS Criteria for Potentially Inappropriate Medication Use in Older Adults List of potentially inappropriate medications (PIMs) for elderly Advantages Quick and easy reference for problem drugs Recent data (2012 update) Disadvantages Limited scope Limited evidence, inconclusive 4

START/STOPP Criteria Screening Tool to Alert Doctors to the Right Treatment (START) Screening Tool of Older People s potentially inappropriate Prescriptions (STOPP) Advantages Recommendations for medications that are often omitted with therapeutic alternatives Recent data More patient-centric Disadvantages Limited evidence that outcomes are affected by its use QUESTION #2 Which of the following references can be used to identify potentially inappropriate medication use in the elderly? a) Beers list b) START/STOPP Criteria c) JNC-8 d) A and B e) all of the above What is the concern? Fall Risk Hypoglycemia Hypotension Dizziness Sedation Constipation Urinary Retention Cognitive Impairment Toxicity 5

Anticholinergics Constipation/Urinary Retention Oral Corticosteroids complications Limit treatment to exacerbations (<3 months) Beta Blockers Consider cardio-selective beta blockers if necessary Tricyclic Antidepressants Cognitive impairment Alpha blockers Avoid for treatment of HTN Consider 5-alpha reductase inhibitors as alternatives for treatment of BPH Tamsulosin has less ADEs Alpha agonists Avoid (exception with hypertensive emergencies) 6

Benzodiazepines Cognitive impairment Re-evaluate need for therapy frequently Consider shorter acting benzodiazepines Antihistamines Constipation Urinary retention If treatment for allergies needed: Reserve for PRN use Consider second generation over first generation Consider nasal corticosteroids instead CASE PRESENTATION AB is a 69 year-old female PMH: COPD, Type 2 Diabetes, dyslipidemia, HTN, and HF C/O recent episodes of falling within past 30 days. Dizziness bothers her the most when she gets out of bed in the morning and middle of the night Medication List: Atorvastatin 10mg qam Carvedilol 6.25mg BID Diazepam 10mg BID PRN (typically takes qhs) Lisinopril 40mg qam Metformin 500mg BID Spiriva qday Symbicort 160/4.5mcg, 2 inhalations BID 7

QUESTION #3 Which of the medications on AB s chart may increase her fall risk? a) lisinopril b) diazepam c) atorvastatin d) A and B e) all of the above QUESTION #4 Which of the following counseling points would be appropriate to help AB minimize her fall risk? a) Recommend patient take offending medication(s) at bedtime b) Discuss with patient and provider need for continued use of diazepam c) Recommend patient move slowly and have a grasp on a steady object when changing positions (i.e. sitting to standing) d) B and C e) all of the above 8

Rules of Thumb Consider physiologic changes in geriatric patients Evaluate and treat every patient individually Many elderly patients may take these medications, not all require intervention or recommendations to avoid Screen for adverse events at each interaction Counsel patients thoroughly REFERENCES Beers M, Ouslander J, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825-32. Beyth R, Shorr R. Principles of drugt therapy in older patients: rational drug prescribing. Clin Geriatr Med 2002; 18: 577-592. Fick D, Cooper J, Wade W, et al. Updating the Beers Criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163: 2716-24. Fick D, Waller J, Maclean J, et al. Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilization. J Managed Care Pharm 2001; 7: 40 7-13. Goulding M. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004; 164: 305-312. Gu Q, Dillon C, Burt V. Prescription Drug Use Continues to Increase: US Prescription Drug Data for 2007-2008. NCHS Data Brief; 42. Available at http://www.cdc.gov/nchs/data/databriefsdb42.pdf. Accessed on January 27, 2015 Potentially Harmful Drugs in the Elderly: Beers List. Available at http://pharmacistsletter.therapeuticresearch.com/pl/articledd.aspx?cs=faculty&s=pl&pt=6&fpt=3 1&dd=280610&pb=PL&searchid=50198915#CHART4413. Accessed on January 6, 2015. Reuben D, Herr K, Pacala J, et al. Geriatrics at Your Fingertips. 16 th ed. American Geriatrics Society; 2014. STARTing and STOPPing Medications in the Elderly. Available at http://pharmacistsletter.therapeuticresearch.com/pl/articledd.aspx?pt=2&dd=270906&fromce=092011. Accessed on January 6, 2015. 9